STOCK TITAN

Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Elutia's CEO to participate in panel at Cantor Global Healthcare Conference
Positive
  • Elutia's CEO participating in a panel at a healthcare conference could increase investor confidence
Negative
  • None.

SILVER SPRING, Md., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, will participate on a panel at the Cantor Global Healthcare Conference. The panel discussion will take place in New York on Wednesday, September 27, 2023, at 8:00 am ET.

A live webcast of the panel can be accessed by visiting the Company’s Events & Presentations webpage or by clicking here. A replay will be available on the Company’s website following the event.

Institutional investors interested in meeting with management during the conference may reach out to their Cantor Fitzgerald representative.

About Elutia

Elutia develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com


Elutia Inc.

NASDAQ:ELUT

ELUT Rankings

ELUT Latest News

ELUT Stock Data

108.65M
29.75M
6.98%
60.92%
0.32%
Medical Devices
Biological Products, (no Disgnostic Substances)
Link
United States of America
SILVER SPRING